logo

AMLX’s Stock Journey: What Investors Need to Know About Amylyx Pharmaceuticals Inc’s Performance

Amylyx Pharmaceuticals Inc’s market performance has been stable in recent times. The company’s stock hit a 1-year high of $7.27 on 11/08/24 and a low of $1.58 for the same time frame on 06/17/24.

52-week price history of AMLX Stock

A stock’s 52-week high and low prices can reveal much about its current status and future trajectory. Amylyx Pharmaceuticals Inc’s current trading price is -31.09% away from its 52-week high, while its distance from the 52-week low is 218.10%. The stock’s price range during this period has spanned from $1.58 to $7.27. In the Healthcare sector, the Amylyx Pharmaceuticals Inc’s shares surpassed a trading volume of approximately 0.55 million for the day, which was noticeably lower compared to the average daily volume of 9.0.81 million over the past three months.

Market Capitalization and Financial Performance: An In-Depth Look

Amylyx Pharmaceuticals Inc (AMLX) has experienced a quarterly rise of 43.55% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 443.90M and boasts a workforce of 123 employees.

Making Sense of Trading Volume and Moving Average Data

Based on Barchart.com data, the company’s moving average over the 100-day period was 3.83, with a change in price of -0.53. Similarly, Amylyx Pharmaceuticals Inc recorded 817,645 in trading volume during the last 100 days, posting a change of -9.57%.

Examining AMLX’s Debt-to-Equity Ratio: What You Need to Know

The debt-to-equity (D/E) ratio is a crucial measure that sheds light on a company’s financial health and market standing. It is determined by dividing a company’s overall liabilities by its shareholders’ equity, showing the extent of a company’s debt usage in financing its assets compared to the shareholders’ equity. At the time of writing, the total D/E ratio for AMLX stands at 0.01. Similarly, the long-term debt-to-equity ratio is also 0.00.

AMLX Stock Stochastic Average

Today’s raw stochastic average for Amylyx Pharmaceuticals Inc over the last 50 days is 84.12%.This indicates a increase from the raw stochastic average of the past 20 days, which was 80.68%. Moreover, the company’s Stochastic %K and %D values for the last 20 days were 91.53% and 94.31%, respectively.

AMLX Stock Price Performance Analysis

A mixed performance in the stock price over the year has left investors unsure of what to expect, resulting in a range of outlooks from optimistic to pessimistic. Year to date metric has recorded a gain of 32.54%.However, over the last six months, we can see a weaker performance of 1.01%. Over the last 30 days, the price of AMLX has fallen by 29.46%. And in the last five days, it has surged by 18.44%.

Most Popular